Kovaltry® 250


Lyophilised powder for injection
scheduling status
S4
registration number
52/8.1/0266
What Kovaltry® 250 contains
Recombinant antihaemophilic Factor VIII (octocog alfa).
other ingredients
Calcium chloride Glycine Histidine Polysorbate 80 Sodium chloride Sucrose.
Therapeutic classification
B02BD02.
© 2026 SAHPRA. ALL RIGHTS RESERVED